Galmed Pharmaceuticals (NASDAQ:GLMD – Get Free Report) is projected to release its results before the market opens on Wednesday, April 1st. Analysts expect Galmed Pharmaceuticals to post earnings of ($0.51) per share and revenue of $1.2990 million for the quarter. Galmed Pharmaceuticals Stock Down 5.9% GLMD stock opened at $0.48 on Tuesday. The firm has […]

Vincerx Pharma (NASDAQ:VINC – Get Free Report) is anticipated to issue its resultson Friday, March 27th. Analysts expect the company to announce earnings of ($2.20) per share for the quarter. Vincerx Pharma Stock Performance Shares of VINC opened at $0.01 on Thursday. The company’s fifty day moving average is $0.01 and its 200 day moving […]

Syros Pharmaceuticals (NASDAQ:SYRS – Get Free Report) is anticipated to release its resultson Wednesday, March 25th. Analysts expect Syros Pharmaceuticals to post earnings of ($0.1580) per share for the quarter. Syros Pharmaceuticals Price Performance SYRS stock opened at $0.00 on Monday. Syros Pharmaceuticals has a 52 week low of $0.00 and a 52 week high […]